Evidence map›Paper›PMID 39693312›Full record

ArticlePloS one2024

Towards 90-70-90 targets: Individual and community level factors associated with cervical cancer screening among women of reproductive age in Tanzania: A multi-level analysis based on 2022 Tanzania demographic and health survey.

Yordanos Sisay Asgedom, Aklilu Habte Hailegebireal, Beshada Zerfu Woldegeorgis, Mengistu Meskele Koyira, Beminate Lemma Seifu, Bezawit Melak Fente, Amanuel Yosef Gebrekidan, Habtamu Azene Tekle, Angwach Abrham Asnake, Gizachew Ambaw Kassie

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yordanos Sisay AsgedomDepartment of Epidemiology, College of Health Sciences and Medicine, Wolaita Sodo University, Sodo, Ethiopia.ORCID 0000-0001-5226-1200
Aklilu Habte HailegebirealSchool of Public Health, College of Medicine and Health Sciences, Wachemo University, Hosanna, Ethiopia.
Beshada Zerfu WoldegeorgisSchool of Medicine, College of Health Sciences and Medicine, Wolaita Sodo University, Sodo, Ethiopia.
Mengistu Meskele KoyiraSchool of Public Health, College of Health Sciences and Medicine, Wolaita Sodo University, Sodo, Ethiopia.ORCID 0000-0001-6157-4591
Beminate Lemma SeifuDepartment of Public Health, College of Medicine and Health Science, Samara University, Samara, Afar, Ethiopia.
Bezawit Melak FenteDepartment of General Midwifery, School of Midwifery, College of Medicine & Health Sciences, University of Gondar, Gondar, Ethiopia.
Amanuel Yosef GebrekidanSchool of Public Health, College of Health Sciences and Medicine, Wolaita Sodo University, Sodo, Ethiopia.
Habtamu Azene TekleSchool of Medicine, College of Health Sciences and Medicine, Wolaita Sodo University, Sodo, Ethiopia.
Angwach Abrham AsnakeDepartment of Epidemiology, College of Health Sciences and Medicine, Wolaita Sodo University, Sodo, Ethiopia.
Gizachew Ambaw KassieDepartment of Epidemiology, College of Health Sciences and Medicine, Wolaita Sodo University, Sodo, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCervical cancer is a major public health problem worldwide, and is mainly caused by human papillomaviruses. More than 90% of cervical cancer cases can be prevented by using a human papilloma vaccine and screening. Despite the ongoing global cervical cancer screening target, uptake remains unacceptably low in sub-Saharan Africa such as Tanzania. Although cervical cancer is the leading cause of mortality in Tanzania, evidence on the individual- and community-level factors associated with cervical cancer screening among women of reproductive age is scarce. Therefore, this study aimed to determine the individual- and community-level factors associated with cervical cancer screening among women of reproductive age in Tanzania.

methodsThis study used data from the 2022 Tanzania Demographic and Health Survey (TDHS). A weighted sample of 15,140 women of reproductive age was included in this study. Given the effect of clustering and binary nature of the outcome variable, we used a multilevel binary logistic regression model. The adjusted odds ratio (AOR) with 95% Confidence Interval (CI) was statistically significant. Moreover, the model with the lowest deviance best suited the data.

resultsThe overall uptake of cervical cancer screening among Tanzanian women was 7.28% (95% confidence interval [CI]: 6.87%, 7.70%). Women's age (25-34, 35-49), women with primary, secondary, and higher educational levels, being employed, a high household wealth index, visiting health facilities in the last 12 months, owning mobile phones, urban residence, and southern highlands, Southern, and Zanzibar administrative zones, were significantly associated with cervical cancer screening.

conclusionCervical cancer screening among women in Tanzania was low. Low uptake underscores the need for increased focus on addressing the coverage of the 2030 Sustainable Development Goals (SDGs). The study would help policymakers create programs that consider education, employment, visiting health facilities, mobile phones, wealth, residence, and administrative zones, which would make women undergo cervical cancer screening. Pointing to women living with low cervical cancer screening could help increase their uptake and achieve the targets of the national and World Health Organization.

Indexed as

Early Detection of CancerHealth SurveysUterine Cervical NeoplasmsAdolescentAdultFemaleHumansMass ScreeningMiddle AgedTanzaniaYoung Adult

Identifiers

PMID39693312
PMCPMC11654981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.